Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806700 · ClinicalTrials.gov registry record · NA
Twitter and Diabetes
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 628
- Enrollment target
NCT02806700: Completed NA study, sponsored by University of Pennsylvania.
NCT02806700 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 628 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806700, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 628 participants
- Enrollment target
Study Summary
Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially provides information faster and less expensively than collection from other media channels. Prior work also supports that social media interventions can improve health behavior change (e.g. weight loss, physical activity) and outcomes.The overarching goals of this proposal are to understand the uses and limitations of this communication channel to improve patients' ability to manage their CV health condition.
Primary Outcome
The Patient Activation Measure (PAM) is a validated and reliable tool that assesses a person's ability to manage their health, using a 100-point total score scale and four activation levels. The total score ranges from 0 to 100, with higher scores indicating better outcomes-specifically, higher scores represent better outcomes. The overall score is summed from individual items, reflecting the level of activation and self-management ability. The four levels are: Level 1 (Score: 0-47.0): Lowest a
Interventions
- BEHAVIORAL Twitter Diabetes Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT02806700 record still lists
NCT02806700 is an interventional study that assigns participants to a tested intervention. The registered 628 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Twitter Diabetes Intervention is the first listed.
NCT02806700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02806700 about?
NCT02806700 is a clinical study titled "Twitter and Diabetes". Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially prov...
What is the current status of trial NCT02806700?
This trial is currently completed. It is a NA study. The enrollment target is 628 participants. The study started on 2016-06. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02806700?
The interventions under investigation include: Twitter Diabetes Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02806700?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02806700's enrollment target sits among peer trials
628 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia